SEER earnings date and last-quarter result: last quarter beat, P/E -1.67. Updated 2026-07-23.
Seer (SEER) Research Hub
Seer (SEER) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.93 USD (-2.03%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.67, market cap 0.11B. This hub links to the full technical, earnings and options research available for SEER.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.93 USD (-2.03%) |
| 52-week range | 1.55 USD – 2.38 USD |
| Trend regime | Range |
| 14-day RSI | 20.5 (Oversold) |
| Trailing P/E | -1.67 |
| Market cap | 0.11B |
| Dividend yield | 0.00% |
Available research for SEER
Covered Call on SEER: how it works, illustrative setup around the real 1.93 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SEER: how it works, illustrative setup around the real 1.93 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SEER: how it works, illustrative setup around the real 1.93 USD price, max profit/loss, breakeven and when to use it. Educational.
SEER technical analysis: range, last 1.93 USD, RSI 20.5, 52w range 1.55 USD–2.38 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SEER in?
Seer (SEER) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is SEER in an uptrend or downtrend?
As of 2026-10-26, SEER is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SEER's trailing P/E ratio?
SEER's trailing P/E is -1.67, with a market cap of 0.11B. See the earnings research page for full valuation detail.